Sarcoid arthritis: A review of clinical features, pathology and therapy

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 20, Issue 2, 2003, Pages 95-103

  Torralba, Karina D ^a   Quismorio Jr , Francisco P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anti TNF therapy; Dactylitis; L fgren's syndrome; Sarcoid arthritis; Tenosynovitis

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PREDNISONE; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

ACUTE DISEASE; ARTHRITIS; ARTHROPATHY; ARTHROSCOPY; BODY REGIONS; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GRANULOMATOSIS; HEREDITY; HUMAN; HYPERCOAGULABILITY; IMAGING; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LABORATORY TEST; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REST; REVIEW; RHEUMATIC DISEASE; SACROILIITIS; SARCOID ARTHRITIS; SARCOIDOSIS; SERODIAGNOSIS; SIDE EFFECT; SYNOVITIS; TENDINITIS; TENOSYNOVITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; VEIN THROMBOSIS;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; METHOTREXATE; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037589714     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Kaplan H: Sarcoid arthritis: a review. Arch Intern Med 1963; 112: 162-73.
2. Abril A, Cohen MD: Rheumatological manifestations of sarcoidosis. Bull Rheum Dis 2000; 49: 1-4.
3. Baughman RP, Teirstein AS, Judson MA, et al: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-9.
4. Judson MA, Thompson BW, Rabin DL, et al: The diagnostic pathway to sarcoidosis. Chest 2003; 124: 406-12.
5. Soderlin MK, Borjesson O, Kautianen H, Skogh T, Lerisalo-Repo M: Annual incidence of inflammatory joint disease in a population based study in Southern Sweden. Ann Rheum Dis 2002; 61: 911-5.
6. Glennas A, Kvien TK, Melby K, et al: Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995; 34: 45-50.
7. Visser H, Vos K, Zanelli E, et al: Sarcoid arthritis: clinical characteristics, diagnostic aspects and risk factors. Ann Rheum Dis 2002; 61: 499-504.
8. Gumpel JM, Johns CJ, Shulman LE: The joint disease of sarcoidosis. Ann Rheum Dis 1967; 26: 194-205.
9. Spilberg I, Siltzbach LE, McEwen C: The arthritis of sarcoidosis. Arthritis Rheum 1969; 12: 126-37.
10. Gran JT, Bohmer E: Acute sarcoid arthritis: a favourable outcome? Scand J Rheumatol 1996; 25: 70-3.
11. Caplan JI, Katz WA, Rubenstein M: Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum 1970; 13: 101-11.
12. Pennec Y, Youinou P, Le Goff P, Boles JM, Le Menn G: Comparison of the manifestations of acute sarcoid arthritis with and without erythema nodosum: immunopathogenic significance. Scand J Rheumatol 1982; 11: 13-6.
13. Mana J, Gomez-Vaquero C, Montero A, et al: Löfgren's Syndrome revisited: a study of 186 patients. Amer J Med 1999; 107: 240-5.
14. Johard U, Eklund A: Recurrent Löfgren's syndrome in three patients with sarcoidosis. Sarcoidosis 1993; 10: 125-7.
15. Israel HL, Fish JE: Periarticular ankle sarcoidosis and Löfgren's syndrome. Sarcoidosis 1994; (suppl 1) 11: 379-388.
16. Kellner H, Spathling S, Herzer P: Ultrasound findings in Löfgren's syndrome: Is ankle swelling caused by arthritis, tenosynovitis or periarthritis. J Rheumatol 1992; 19: 38-41.
17. Cantini F, Niccoli L, Olivieri I, et al: Remitting distal lower cxtremity swelling with pitting oedema in acute sarcoidosis. Ann Rheum Dis 1997; 56: 565-6.
18. Perruquet IL, Harrington TM, Davis DE, Viozzi FI: Sarcoid arthritis in a north american caucasian population. J Rheumatol 1984; 11: 521-5.
19. Siltzbach LE, Duberstein JL: Arthritis in sarcoidosis. Clin Orthop 1968; 57: 31-50.
20. Grigor RR, Hughes GR: Chronic sarcoid arthritis. Br Med J 1976; 2: 1044.
21. Boyd RE, Andrews BS: Sarcoidosis presenting as cutaneous ulceration, subcutaneous nodulcs and chronic arthritis. J Rheumatol 1981; 8: 311-6.
22. Scott DG, Porto LO, Lovell CR, Thomas GO: Chronic sarcoid synovitis in the Caucasian: an arthroscopic and histological study. Ann Rheum Dis 1981; 40: 121-3.
23. Bjarnason DF, Forrestor DM, Swezey RL: Destructive arthritis of the large joints; a rare manifestation of sarcoidosis. J Bone Joint Surg 1973; 55A: 618-22.
24. Feldman C: Chronic sarcoid arthritis. Rheumatol Rehabil 1981; 20: 18-20.
25. Merle M, Bour C, Foucher G, Saint Laurent Y: Sarcoid tenosynovitis in the hand. J Hand Surg 1986; 11: 281-6.
26. Landi A, Brooks D, De Santis G. Sarcoidosis of the hand - report of two cases. J Hand Surg 1983; 8: 197-200.
27. Larsen TK: Tenosynovitis as initial diagnosis of sarcoidosis. Scand J Plast Reconst Surg Hand Surg 1996; 30: 157-9.
28. Katzman BM, Caligiuri DA, Klein DM, Perrier G, Dauterman PA: Sarcoid flexor tenosynovitis of the wrist: a case report. J Hand Surg 1997; 22: 336-7.
29. Ortiz V, Holgado S, Olive A, Fite E: Achilles tendonitis as the presentation form of Löfgren's syndrome. Clin Rheumatol 2000; 19: 169-70.
30. Crowder SW, Jaffey LH. Sarcoidosis presenting as Achilles tendonitis. J R Soc Med 1995; 88: 335-6.
31. Sukenik S, Hendler N, Yerushalmi B, Buskila D, Liberman N: Jaccoud's-type arthropathy: an association with sarcoidosis. J Rheumatol 1991; 18: 915-7.
32. Rothschild BM, Pingitore C, Eaton M: Dactylitis: impilcations for clinical practice. Sem Arthritis Rheum 1998; 28: 41-7.
33. Pitt P, Hamilton EB, Innes EH, Morley KD, Monk BE, Hughes GR: Sarcoid dactylitis. Ann Rheum Dis 1983; 42: 634-9.
34. Rodriguez-Gomez M, Fernandez-Sueiro JL, Willisch A, Fernandez-Dominguez L, Lopez-Barros G, Vega-Vazquez F: Multifocal dactylitis as the sole clinical expression of sarcoidosis. J Rheumatol 2000; 27: 245-7.
35. Leibowitz MR, Essop AR, Schamroth CL, Blumsohn D, Smith EH: Sarcoid dactylitis in black South African patients. Semin Arthritis Rheum 1985; 14: 232-7.
36. Kotter I, Durk H, Saal JG: Sacroiliitis in sarcoidosis: case reports and review of the literature. Clin Rheumatol 1995; 14: 695-700.
37. Griep EN, Van Spiegel PI, Van Soesbergen RM: Sarcoidosis accompanied by pulmonary tuberculosis and complicated by sarcoiliitis. Arthritis Rheum 1993; 36: 716-21.
38. Oreskes I, Sitzbach LE: Changes in rheumatoid factor activity during the course of sarcoidosis. Ant J Med 1968; 44: 60-7.
39. Giotaki HA: Biochemical and immunological parameters of sarcoid patients in west Greece. Sarcoidosis 1989; 6: 135-7.
40. Olenchock SA, Marx JJ Jr, Mull JC: Immunology of clinically inactive sarcoidosis: serum factors. Ann Allergy 1981; 47: 28-31.
41. Veien NK, Hardt F, Bendixen G, et al: Humoral and cellular immunity in sarcoidosis. Acta Med Scand 1978; 203: 321-326.
42. Weinberg I, Vasiliev L, Gotsman I: Anti-dsDNA antibodies in sarcoidosis. Semin Arthirits Rheum 2000; 29: 328-31.
43. Quismorio FP Jr, Sharma OP, Chandor S: Immunopathological studies on the cutaneous lesions in sarcoidosis. Br J Dermatol 1977; 97: 635-42.
44. Amital H, Klemperer I, Blank M: Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. Int Arch Allergy Immunol 1992; 99: 34-6.
45. Ainslie GM, Benatar SR: Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med 1985; 55: 253-70.
46. Arbustini E, Grasso M, Leo G: Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Resp Crit Care Med 1996; 153: 851-4.
47. Sequeira W, Stinar D: Serum angiotensin-converting enzyme levels in sarcoid arthritis. Arch Intern Med 1986; 146: 125-7.
48. Kremer JM: Histologic findings in siblings with acute sarcoid arthritis association with the B8, DR3 phenotype. J Rheumatol 1986; 13: 593-7.
49. Varkey B: Synovial fluid in sarcoid arthritis. Ann Int Med 1974; 81: 557.
50. Palmer DG, Schumacher HR: Synovitis with non-specific histological changes in synovium in chronic sarcoidosis. Atin Rheum Dis 1984; 43: 778-82.
51. Sokoloff L, Bunim JJ: Clinical and pathological studies of joint involvement in sarcoidosis. N Eng J Med 1959; 260: 841-7.
52. Bianchi FA, Keech MK: Sarcoidosis with arthritis. Ann Rheum Dis 1964; 23: 88-110.
53. Rayner CK, Burnet SP, McNeil JD: Osseous sarcoidosis - a magnetic resonance imaging diagnosis. Clin Exp Rheumatol 2002; 20: 546-8.
54. Blacksin MF, Acello AN, Kowalec J, Lyons MM: Osseous sarcoidosis of the foot: detection by MR imaging. AJR Am J Roentgenol 1994; 163: 1444-5.
55. Blank NM, Steininger H, Kalden JR, Burkhardt H: Symptomatic bone lesion of the tibia head as onset manifestation of sarcoidosis. J Rheumatol 1999; 26: 936-7.
56. Powers RA, Limbird TJ: MRI of the knee in sarcoidosis: synovial and marrow involvement. J Comp Assist Tomogr 1994; 18: 313-4.
57. Brewerton DA, Cockburn C, James DCO, James DG, Neville E: HLA antigens in sarcoidosis. Clin Exp Immunol 1977; 27: 227-9.
58. Hedfors E, Lindstrom F: HLA-B8/DR3 in sarcoidosis. Tissue Antigens 1983; 22: 200-3.
59. Krause A, KM Goebel KM: Class II MHC antigen (HLA-DR3) predisposes to sarcoid arthritis. J Clin Lab Immunol 1987; 24: 25-7.
60. Shetty AK, Gedalia A: Sarcoidosis in children. Curr Probl Pediatr. 2000; 30: 149-76.
61. Lindsley CB, Petty RE: Overview and report on international registry of sarcoid arthritis in childhood. Curr Rheumatol Rep 2000; 2: 343-8.
62. Singh R, Menon Y, Cuchacovich R, Espinoza LR, Wilson WA, Gedalia A: Comparison of childhood with adult onset sarcoidosis in patients attending rheumatology clinics. Arthritis Rheum 2002; 46: S816.
63. North AF Jr, Fink CW, Gibson WM, et al: Sarcoid arthritis in children. Amer J Med 1970; 48: 449-55.
64. Hafner R, Vogel P: Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 1993; 11: 685-91.
65. Rosenberg AM, Yee EH, MacKenzie JW: Arthritis in childhood sarcoidoisis. J Rheumatol 1983; 10: 987-90.
66. Yotsumoto S, Takahashi Y, Takei S, Shimada S, Miyata K, Kanzaki T: Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis. J Am Acad Dematol 2000; 43: 969-71.
67. Sakurai Y, Nakajima M, Kamisue S, et al: Preschool sarcoidosis mimicking juvenile rheumatoid arthrilis: the significance of gallium scintigraphy and skin biopsy in the differential diagnosis. Acta Paediatr Jpn 1997; 39: 74-8.
68. Ukae S, Tsutsumi H, Adachi N, Takahashi H, Kato F, Chiba S: Preschool sarcoidosis manifesting as juvenile rheumatoid arthritis: A case report and a review of the literature of Japanese cases. Acta Paediatr Jpn 1994; 36: 515-8.
69. Cimaz R, Ansell BM: Sarcoidosis in the pediatric age. Clin Exp Rheumatol 2002; 20: 231-237.
70. Lindsley CB, Godfrey WA: Childhood sarcoidosis manifesting as juvenile rheumatoid arthritis. Pediatrics 1985; 76: 765-8.
71. Paller AS, Roenigk HH Jr, Caro WA: Extensive ichthyosiform sarcoidosis in a patient with juvenile rheumatoid arthritis. Arch Dermatol 1985; 121: 171-2.
72. Mallory SB, Paller AS, Ginsburg BC, McCrossin MB, Abernathy R: Sarcoidosis in children: differentiation form juvenile rheumatoid arthritis. Pediatric Dermatol 1987; 4: 313-9.
73. Baughman RP, Winget DB, Lower EE: Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 60-6.
74. Baughman RP, Lower EE: A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-6.
75. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG: Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995; 34: 642-4.
76. Gedalia A, Molina JF, Ellis GS Jr, Galen W, Moore C, Espinoza LR: Low-dose methotrexale therapy for childhood sarcoidosis. J Pediatr 1997; 130: 25-9.
77. Adams JS, Diz MM, Sharma OP: Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989; 111: 437-8.
78. Sharma OP: Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis and neurological involvement. Arch Neurol 1998; 55: 1248-4.
79. Allanore Y, Perrot S, Menkes CJ, Kahan A: Management of a patient with sarcoid calcaneitis and dactylitis. Joint, Bone, Spine 2001; 68: 175-7.
80. Wilcox A, Bharadwaj P, Sharma OP. Bone Sarcoidosis. Curr Opinion Rheumatol 2000; 12: 321-30.
81. Kaplan H. Sarcoid arthritis with a response to colchicine: report of two cases. N Eng J Med 1960; 263: 778.
82. Harris ED Jr, Millis M: Treatment with colchicine of the periarticular inflammation associated with sarcoidosis: a need for continued appraisal. Arthritis Rheum 1971; 14: 130-3.
83. Rubinstein I, Baum GL: Colchicine therapy in sarcoid arthropathy. Pediatrics 1986; 78: 717-8.
84. Ehrenfeld M, Miller M, Soric R, Baum J, Tenenbaum J: Intravenous colchicine in acute sarcoid arthropathy. [Letter] Journal of Rheumatol 1984; 11: 412-3.
85. Wallace SI, Bernstein D, Diamond H: Diagnostic value of the colchicine therapeutic trial. JAMA 1967; 199: 525-8.
86. Agostini C, Meneghin A, Semenzato G: T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med 2002; 8: 435-40.
87. Prasse A, Georges CG, Blller H, et al: Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122: 241-8.
88. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Muller-Quernheim J: Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Invest Med 1998; 46: 223-31.
89. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW: The relationship between alveolar macrophage TNF, IL-1 and PGE2 release, alveolitis and disease severity in sarcoidosis. Chest 1993; 103: 832-8.
90. Yee AMF, Pochapin MB: Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-[alpha] therapy. Ann Intern Med 2001; 135: 28-31.
91. Baughman RP, Lower EE: Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 70-4.
92. Sweiss NJ, Ellman MH, Curran JJ, Park C: TNF-inhibition as novel treatment for refractory sarcoidosis. Arthritis Rheum 2002; 46: S817.
93. Fahey SM, Bolster M, Silver RM, Judson M: Treatment of refractory sarcoidosis with infliximab (Remicade). Arthritis Rheum 2002; 46: S815.
94. Pettersen JA, Zochodne DW, Bell RB, Martin L, Hill MD: Refractory neurosarcoidosis responding to infliximab. Neurology 2002; 59: 1660-1.
95. Sweiss NJ, Ellman MH, Curran J, Utset TO, Park C: TNF-inhibition as novel treatment for refractory sarcoidosis. Arthritis Rheum 2001; 44: 409S.
96. Zabel P, Entzian P, Dalhoff, Schlaak M: Pentoxyfilline in treatment of sarcoidosis. Am J Resp Crit Care Med 1997; 155: 1665-9.
97. Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE: Thalidomide for chronic sarcoidosis. Chest 2002; 122: 227-32.